CG-209

N/A

Report date: 2022/05/10 11:41:04
NME

Base Information

Drug NameCG-209
Drug Alias NameCG209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConverGene LLC
China Registration ClassN/A

Develop Information

Active CompaniesConverGene LLC
Inactive CompaniesN/A
Active IndicationsPsychotic Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A